Literature DB >> 29258334

A comprehensive review of recent studies on pharmacokinetics of traditional Chinese medicines (2014-2017) and perspectives.

Peiying Shi1, Xinhua Lin2, Hong Yao2.   

Abstract

Traditional Chinese medicines (TCMs) have a long history for safely treating human diseases. Unlike western medicine, TCMs usually contain multiple components synergistically and holistically acting on the diseases. It remains a big challenge to represent rationally the in vivo process of multiple components of TCMs for understanding the relationship between administration and therapeutic effects. For years, efforts were always made to face the challenge, and the achievements were obvious. Here, we give an comprehensive overview of the recent investigation progress (from 2015 to 2017, except the part of 'integrated pharmacokinetics of TCMs' from 2014 to 2017 and the part of 'reverse pharmacokinetics in drug discovery from natural medicines' in 2014) on pharmacokinetics of TCMs, mainly referring to the following six aspects: (1) classical pharmacokinetic studies on TCMs; (2) absorbed components and metabolites identification of TCMs; (3) pharmacokinetic herb-drug interactions and herb-herb interactions with TCMs; (4) integrated pharmacokinetics of TCMs; (5) pharmacokinetic and pharmacodynamic combination studies to dissect the action mechanisms of TCMs; and (6) reverse pharmacokinetics in drug discovery from natural medicines. Finally, based on the insights from the recent progress and our latest efforts, we propose new perspectives on the integrated pharmacokinetics of TCMs.

Entities:  

Keywords:  Pharmacokinetics; integrated pharmacokinetics of TCMs; pharmacodynamics; pharmacokinetics of multiple components; traditional Chinese medicines

Mesh:

Substances:

Year:  2017        PMID: 29258334     DOI: 10.1080/03602532.2017.1417424

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  5 in total

1.  Tissue Distribution, Excretion, and Interaction With Human Serum Albumin of Total Bioflavonoid Extract From Selaginella doederleinii.

Authors:  Bing Chen; Dafen Xu; Zhijun Li; Yafei Jing; Luping Lin; Shaoguang Li; Liying Huang; Xiuwang Huang; Ailin Liu; Xinhua Lin; Hong Yao
Journal:  Front Pharmacol       Date:  2022-04-29       Impact factor: 5.988

2.  An integrated pharmacokinetic study of Dengzhanxixin injection in rats by combination of multicomponent pharmacokinetics and anti-myocardial ischemic assay.

Authors:  Jianyong Huang; Ya Su; Chunlei Yang; Shaoguang Li; Youjia Wu; Bing Chen; Xinhua Lin; Liying Huang; Hong Yao; Peiying Shi
Journal:  RSC Adv       Date:  2019-08-13       Impact factor: 4.036

3.  Self-assembled aggregations in Coptidis Rhizoma decoction dynamically regulate intestinal tissue permeability through Peyer's patch-associated immunity.

Authors:  Qing-Qing Zhang; Ye Yang; Rong-Rong Ren; Qing-Qing Chen; Jing-Jing Wu; Yu-Yu Zheng; Xiao-Hui Hou; Yu-Feng Zhang; Ming-Song Xue; Deng-Ke Yin
Journal:  Chin Herb Med       Date:  2021-06-30

4.  Simultaneous Determination of Chlorogenic Acid Isomers and Metabolites in Rat Plasma Using LC-MS/MS and Its Application to A Pharmacokinetic Study Following Oral Administration of Stauntonia Hexaphylla Leaf Extract (YRA-1909) to Rats.

Authors:  Won-Gu Choi; Ju-Hyun Kim; Dong Kyun Kim; Yongnam Lee; Ji Seok Yoo; Dae Hee Shin; Hye Suk Lee
Journal:  Pharmaceutics       Date:  2018-09-02       Impact factor: 6.321

5.  Development of a HPLC-MS/MS Method to Determine 11 Bioactive Compounds in Tongmai Yangxin Pill and Application to a Pharmacokinetic Study in Rats.

Authors:  Jiayuan Shen; Juan Wei; Li Li; Huizi Ouyang; Yanxu Chang; Xiaopeng Chen; Jun He
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-26       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.